Improvement in Atopic Dermatitis Signs and Symptoms With Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.15% or 0.05%: the 52-Week Phase 3 INTEGUMENT-OLE Trial in ≥2-year-olds

Authors

• H. Chih-ho Hong
• Eric Simpson
• Lawrence F. Eichenfield
• Alexandra Golant
• Adelaide A. Hebert
• Amy Paller
• April Armstrong
• Linda F. Stein Gold, Henry Ford HealthFollow
• Jonathan I. Silverberg
• Patrick Burnett
• Diane Hanna
• Melissa S. Seal
• Brett Stephenson

Recommended Citation

Hong H, Simpson E, Eichenfield LF, Golant A, Hebert AA, Paller A, Armstrong A, Stein Gold LF, Silverberg JI, Burnett P, Hanna D, Seal MS, Stephenson B. Improvement in Atopic Dermatitis Signs and Symptoms With Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.15% or 0.05%: the 52-Week Phase 3 INTEGUMENT-OLE Trial in ≥2-year-olds. J Invest Dermatol 2025; 145(11):1.

Document Type

Conference Proceeding

Publication Date

11-10-2025

Publication Title

J Invest Dermatol

Keywords

Dermatology

Volume

145

Issue

11

First Page

1